A known sputum positive pulmonary tuberculosis patient currently on INH, rifampicin, pyrizinamide and ethambutol is found to be HIV positive. His CD4 count was 100/ L and viral load was more than 50,000 copies/ml. Which of the following antiretroviral drug should be avoided –
Correct Answer: Ritonavir
Description: Rifampicin is a potent inducer of enzymes of the cytochrome p450 system, lowers serum levels of many HIV protease inhibitors and some nonucleoside reverse transcriptase inhibitors.
In such cases rifabutin which has much less enzyme inducing activity has been recommended in place of rifampin.
Thus, for the patient in question, level of both indinavir and Ritonavir will be reduced as both are protease inhibitors. So which drug should be avoided
According to Harrison
"Both rifampicin and rifabutin should be avoided in patients on Ritonavir."
In general the standard t/t regimens are equally efficacous in HIV negative and HIV positive. However adverse drug affect may be more pronounced in HIV infected patients.
Category:
Medicine
Get More
Subject Mock Tests
Practice with over 200,000 questions from various medical subjects and improve your knowledge.
Attempt a mock test nowMock Exam
Take an exam with 100 random questions selected from all subjects to test your knowledge.
Coming SoonGet More
Subject Mock Tests
Try practicing mock tests with over 200,000 questions from various medical subjects.
Attempt a mock test now